For manufacturers in the Life Sciences industry, production challenges often occur in these four areas—production readiness, equipment reliability, personnel effectiveness and facility/line efficiency. In this post, I’ll focus on equipment reliability, and specifically, unplanned downtime.
Flow is the foundation of world class production processes. Impediments to flow result in waste (transportation, inventory, motion, waiting, over-processing, over-production, defects). Unfortunately, digital solutions are often leveraged to address observed wastes in production processes without first addressing foundational problems.
In a presentation at the ACHEMA Pulse virtual conference this year, Emerson’s Alan Johnston shared how fast rollout of COVID vaccine manufacturing has changed the mindset of how quickly a new therapy can move from development to commercial manufacturing and ultimately to the consumer.
Accelerating vaccine development requires unprecedented flexibility in managing data. With increasing integration between product lifecycle management systems and software—like distributed control systems (DCS) and manufacturing execution systems (MES)—data, recipes, and processes can be digitally altered, shared, and used to scale across the lifecycle.
Technology has continued to advance and provide ways to assist pharmaceutical & biopharmaceutical manufacturers with production readiness. Improper set up and qualification of automation and information management production applications cause start-up and product changeover delays, as well as slow performance during production runs.
At Texas A&M University’s Mary Kay O’Connor Process Safety Center’s 76th Instrumentation and Automation Symposium, Emerson’s Greg McMillan presented on Bioreactor Control and Optimization using Digital Twin technology.
In an Intech article, Three strategies help life sciences companies implement more successful review by exception, Emerson’s Emilee Cook shares ways for these manufacturers to improve this workflow.
In a Jersey’s Best article, Powerful AI technology is changing the way N.J. operates, for the better, Emerson’s Dennis Belanger explains how AI is used, “…as a monitoring tool to understand the condition of eggs that are often used to create vaccines to combat the influenza virus…”
Have you wondered how some of the leading pharmaceutical and biopharmaceutical manufacturers have developed and tested their COVID-19 vaccine candidates in record time? In a Pharma Manufacturing article, The new requirement to fast-track vaccines, Emerson group president for the Systems and Software business, Jim Nyquist, shares ways in which these feats were accomplished.
Emerson’s Michalle Adkins will be discussing villains and heroes in knowledge management at the fully digital November 2-6, 2020 ISPE Annual Meeting and Expo.
The whitepaper, How to Simplify Your Pneumatic Valve Installation to Improve Your Drug Manufacturing Operation, highlights the critical role that pneumatic valve systems play across the drug development lifecycle—from drug discovery and production, to packaging and utilities.
Emerson’s Michalle Adkins and Ron Rossbach will host a webinar on reducing time to market for new therapies—a key opportunity for pharmaceutical and biopharmaceutical manufacturers. This webinar will take place on August 13 at 15:00 CET – Europe / 09:00 EDT.
We invite you to follow us on Facebook, LinkedIn, Twitter and YouTube to stay up to date on the latest news, events and innovations that will help you face and solve your toughest challenges.
Just post a link to the entry and send us a quick note so we can share your work. Thank you very much.
Our Global Community
Emerson Exchange 365
This blog features expert perspectives from Emerson's automation professionals on industry trends, technologies, and best practices. The information shared here is intended to inform and educate our global community of users and partners.